Transplant Diagnostics Market Size to Reach USD 7.08 Billion in 2028, Says Reports and Data

Increasing number of organ transplantation procedures and rapid adoption of advanced and high-throughput transplant diagnostic methods to bolster market growth

The global transplant diagnostics market size is expected to reach USD 7.08 billion in 2028 at a CAGR of 7.5%, according to a latest report by Reports and Data. Rapidly increasing organ transplantation procedures worldwide, rise in organ donation activities, increase in prevalence of chronic diseases, and growing cases of infectious diseases are some key factors driving global transplant diagnostics market revenue growth. Growth of this market is further supported by surging demand for pre-transplant diagnostics, rising demand for advanced and high-throughput diagnostic tools for organ transplant, technological advancements in transplant diagnostic solutions, and emergence of novel techniques such as Next-Generation Sequencing (NGS) technology.

Transplant diagnostic tools improve the effectiveness and outcomes of transplantation procedures and find significant applications in pre-transplant screening for donor eligibility, immunogenetics testing, Human Leukocyte Antigen (HLA) tests, etc. The tools aid in detection of post-transplant acute rejection and manage immunosuppression levels in transplant patients. Moreover, these eliminate chances of complications such as infection or graft failure. Transplant diagnostics generally consist of HLA tests, blood type testing, serology tests, and crossmatch. The global transplant diagnostics market growth is further supported by rising risks associated with organ transplantation, advantages of new techniques over traditional methods, and rising adoption of personalized medicine and stem cell therapy.

Access Free sample PDF Copy of the Report @

Some Key Highlights from the Report:

  • Based on technology type, the molecular assay technologies segment is expected to account for largest revenue share over the forecast period. Growth of this segment is driven by rising adoption of transplant diagnostic techniques, advancements in these techniques, and rising adoption of PCR-based technologies due to their enhanced accuracy, real-time sample analysis, lower risks, and lesser turnaround time. 
  • Among the end-use segments, the independent reference laboratories segment is expected to account for largest revenue share over the forecast period, mainly driven by rising number of organ transplantation procedures, increasing research & development activities in pharmaceutical and biotechnology sectors, and rapid automation of diagnostic laboratories.
  • North America emerged as the leading regional market in terms of revenue share contribution to the global transplant diagnostics market in 2020 and the trend is expected to continue over the forecast period. Revenue growth of the market in this region is driven by rising number of organ transplant procedures, increasing adoption of advanced diagnostic techniques, augmented government support to raise awareness about organ donation, and presence of state-of-the-art healthcare infrastructure.  
  • The leading companies operating in the global transplant diagnostics market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche, Bio-Rad Laboratories, Inc., Abbott Laboratories, Immucor Transplant Diagnostics, Inc., Qiagen N.V., BioMérieux SA, GenDx, Omixon Ltd., Illumina, Inc., Affymetrix, Inc., CareDx, Luminex Corporation, Hologic Inc., Becton, Dickinson and Company, CareDx, Biofortuna, Takara Bio, and BAG Healthcare.

Buy now your Exclusive copy of Report @

For the purpose of this report, the global transplant diagnostics market is segmented based on product type, technology type, transplant type, application, end-use, and region:

By Product Type (Revenue, USD Billion; 2018-2028)

  • Instruments
  • Reagents & Consumables
  • Software & Services

By Technology Type (Revenue, USD Billion; 2018-2028)

  • Molecular Assay Technologies
    • PCR-based Molecular Assays
      • Real-time PCR
      • Sequence-specific Oligonucleotide-PCR
      • Sequence-specific Primer-PCR
      • Others
    • Sequencing-based Molecular Assays
      • Next-generation Sequencing
      • Sanger Sequencing
      • Others
  • Non-molecular Assay Technologies

By Transplant Type (Revenue, USD Billion; 2018-2028)

  • Solid Organ Transplantation
    • Heart Transplantation
    • Lung Transplantation
    • Liver Transplantation
    • Kidney Transplantation
    • Pancreas Transplantation
    • Others
  • Bone marrow Transplantation
  • Stem Cell Transplantation
  • Soft Tissue Transplantation

By Application (Revenue, USD Billion; 2018-2028)

  • Diagnostic Applications
    • Pre-transplantation Diagnostics
      • Blood Profiling
      • Infectious Disease Testing
      • Histocompatibility Testing
    • Post-transplantation Diagnostics
  • Research Applications

By End-use (Revenue, USD Billion; 2018-2028)

  • Hospitals & Transplant Centers
  • Independent Reference Laboratories
  • Research Laboratories & Academic Institutes
  • Others

Request for Custom Research @

By Region (Revenue, USD Billion; 2018-2028)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of the Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Rest of the Middle East & Africa

Explore Reports and Data's Prime Analysis of the global Pharmaceutical & Healthcare Industry:

Cancer Stem Cells Market Size, Share, Trends By Treatment Type (Allogeneic Stem Cell Transplants, Bone Marrow Stem Cell Transplants, Autologous Stem Cell Transplants, Syngeneic Stem Cell Transplants), By Disease Type, And By End User, Forecasts To 2027

Artificial Red Blood Cells Market By Product Type, Source, Distribution Channel (Hospitals, Clinics, Blood Banks), Application (Anemia, Organ Transplant, Injuries & Trauma, Cardiovascular Diseases, Maternal Conditions), Forecasts To 2027

Acute Myeloid Leukemia Therapeutics Market By Regimen (DC Regimen, AVD Regimen, VCD Regimen), By Treatment (Chemotherapy, Radiation therapy, Stem Cell Transplant, Targeted Therapy) And By End-user (Hospital, Retails Drug Stores, Ambulatory Care Centers, Clinics), Forecasts To 2027

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web:

Direct Line: +1-212-710-1370


Read Full Press Release:

Back to news